AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Venlusk 37.5mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Sanix Formulation Pvt Ltd

Salt Composition

Venlafaxine (37.5mg)

Overview Venlusk 37.5mg Tablet ER

Axilon 37.5mg Extended-Release Tablets are indicated for managing depressive and anxiety disorders. This medication modifies brain chemistry responsible for anxiety symptoms like agitation, unease, impaired focus, tiredness, perspiration, rapid heartbeat, and intrusive thoughts. Axilon 37.5mg ER should be administered with food, consistently at the same time daily to ensure stable blood levels. Missed doses should be taken promptly upon recall; do not skip doses, and complete the prescribed course even with symptom improvement. Abrupt cessation is discouraged due to potential symptom exacerbation. Commonly reported side effects include queasiness, vomiting, sleep disturbances, reduced appetite, nervousness, bowel irregularity, increased perspiration, and sexual difficulties. Drowsiness and dizziness are possible; avoid activities requiring alertness until the medication's effects are known. These side effects are generally transient and self-limiting. Persistent or troublesome side effects warrant medical attention. Prior to commencing Axilon 37.5mg ER, disclose any kidney, heart, or liver conditions, or a history of seizures to your physician. Report any unusual shifts in mood or behavior, new or worsening depression, or suicidal ideation immediately to your doctor.

Uses of Venlusk 37.5mg Tablet ER

Mood disorders encompassing depressive and anxiety symptoms

Major Benefits of Venlusk 37.5mg Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 37.5mg extended-release Venlusk tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.

Common Side effects of Venlusk 37.5mg Tablet ER:

  • Nausea
  • Vomiting
  • Dizziness
  • Insomnia (difficulty in sleeping)
  • Decreased appetite
  • Anxiety
  • Constipation
  • Increased sweating
  • Sexual dysfunction

How to use Venlusk 37.5mg Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Venlusk 37.5mg Extended-Release Tablet should be taken with a meal.

How Venlusk 37.5mg Tablet ER works:

Venlusk 37.5mg Extended-Release tablets elevate brain concentrations of serotonin and norepinephrine, neurotransmitters crucial for emotional equilibrium.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Venlusk 37.5mg extended-release tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Venlusk 37.5mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Venlusk 37.5mg tablets are likely unsafe for breastfeeding mothers. Preliminary evidence indicates potential transfer to breast milk, posing a risk to infants. Close observation of infants for drowsiness and healthy weight gain is recommended.

DrivingDrivingUNSAFE

Driving ability may be impaired by Venlusk 37.5mg Extended-Release Tablets due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving skills.

KidneyKidneyCAUTION

Extended-release Venlusk 37.5mg tablets require careful administration for individuals with impaired kidney function. Dosage modification of Venlusk 37.5mg extended-release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with hepatic impairment should exercise caution when using Venlusk 37.5mg extended-release tablets. Dosage modification of Venlusk 37.5mg extended-release tablets may be necessary. Physician consultation is advised.

What if you forget to take Venlusk 37.5mg Tablet ER :

Should you forget a Venlusk 37.5mg Extended-Release Tablet, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.

Facts to Know About Venlusk 37.5mg Tablet ER

LabelValue
Chemical Type Anisole-based compound
Developing Habits No.
Type of Therapy Neuroscience (Central Nervous System)
Actions SNRIs (serotonin-norepinephrine reuptake inhibitors)

FAQs on Venlusk 37.5mg Tablet ER

Sedation is a possible side effect of Venlusk 37.5mg Tablet ER. Inform your doctor about any other sleep aids you're using before starting this medication.
Yes. Venlusk 37.5mg Extended-Release tablets are classified as psychotropic medication; psychotropic drugs affect mental processes, emotions, and behavior.
Venlusk 37.5mg Extended-Release tablets are not narcotics. Narcotics are opioid derivatives, such as heroin and morphine, known for their sedative effects.
Venlusk 37.5mg tablets, whether ER or XR, are the same extended-release medication. This formulation releases the drug slowly, maintaining consistent therapeutic levels. Extended-release tablets therefore reduce the frequency of dosing.
Mirtazapine and Venlafaxine ER 37.5mg tablets should not be taken together. This combination carries a serious risk of serotonin syndrome, a potentially life-threatening condition. Symptoms can include agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma.
Concomitant use of citalopram and Venlafaxine ER 37.5mg tablets is contraindicated due to the risk of serotonin syndrome. This potentially fatal condition may manifest as agitation, hallucinations, nausea, vomiting, diarrhea, rapid heart rate, fluctuating blood pressure, high fever, and coma. Alternative medications should be considered.
P-glycoprotein effluxes Venlusk 37.5mg Tablet ER from the brain; however, studies indicate that Venlusk 37.5mg Tablet ER and its metabolite can inhibit p-glycoprotein.
Venlusk 37.5mg Extended-Release tablets are absorbed in the intestine following hepatic metabolism.
Venlusk 37.5mg Extended-Release Tablets treat generalized depression. Always consult your physician before use.
Venlusk 37.5mg ER tablets may cause sustained blood pressure increases in some patients. Regular blood pressure monitoring is recommended for those taking this medication; dose reduction or discontinuation may be necessary.
Constipation is a known side effect of Venlusk 37.5mg ER tablets. Increase fiber and water intake, and consider using laxatives. Your doctor can provide further management strategies. Consult your doctor if constipation persists or worsens.
Yes, Venlusk 37.5mg Extended-Release tablets have been associated with weight loss in some patients. Studies show this effect increases with dosage and prolonged use. Consult your physician if this is concerning.
Venlusk 37.5mg Extended-Release Tablets are not habit-forming.
Consult your doctor before substituting tablets for capsules; self-medication changes can alter drug release, potentially causing ineffective treatment, side effects, or treatment failure due to differing formulations.
Yes, gabapentin can be used with Venlafaxine ER 37.5mg, but only under a doctor's supervision. Concurrent use may increase drowsiness, sleepiness, and impair concentration. Exercise caution.
Desvenlafaxine is the active ingredient in Venlafaxine ER 37.5mg tablets.
Venlusk 37.5mg Extended-Release Tablets are not FDA-approved for fibromyalgia, although some studies suggest potential benefits. Always consult your physician before using this medication for fibromyalgia.
While not FDA-approved for nerve pain, Venlusk 37.5mg Extended-Release tablets demonstrate efficacy in treating this condition in some research, leading to its off-label use.
Venlusk 37.5mg Extended-Release tablets affect brain neurotransmitter levels, resulting in reduced appetite, an effect that increases with higher doses.
Experience decreased sex drive or impotence? Consult your doctor; alternative medications may be available. Do not discontinue Venlusk 37.5mg Tablet ER without medical supervision; doing so may worsen side effects.
Venlusk 37.5mg Tablet ER
55
MRP 63
13% off